Ensysce Biosciences
ENSC · NASDAQ
$0.4986−$0.0043 (−0.86%)TodayMarket closed ·
Prev close $0.5029
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 57.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.51 | -$0.20 | +60.8% |
| Q1 FY26 | -$0.7446 | -$0.52 | +30.2% |
| Q4 FY25 | -$1.29 | -$0.75 | +41.6% |
| Q3 FY25 | -$0.8823 | -$1.29 | −46.2% |
| Q2 FY25 | -$1.20 | -$0.79 | +34.4% |
| Q1 FY25 | -$3.08 | -$1.39 | +54.8% |
| Q4 FY24 | -$2.79 | -$2.90 | −4.0% |
| Q3 FY24 | -$4.51 | $1.05 | +123.3% |
Earnings calls
- Special Call - Ensysce Biosciences, Inc.
- Shareholder/Analyst Call - Ensysce Biosciences, Inc.
- Shareholder/Analyst Call - Ensysce Biosciences, Inc.
- ENSC - Earnings call Q4 2023
- Special Call - Ensysce Biosciences, Inc.
- Shareholder/Analyst Call - Ensysce Biosciences, Inc.
- Special Call - Ensysce Biosciences, Inc.
- Shareholder/Analyst Call - Ensysce Biosciences, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.